Experimental bleomycin lung in mice: A contribution to the pathogenesis of pulmonary fibrosis
The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A phase 1 trial consisting of 72 patients randomized to receive placebo versus various escalating doses of SHR-1906 demonstrated that it was safe and well tolerated [185].”
From Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF) (2024) · cites this paper as [185]
Citations
Cites
CRYSTAL, R. G., FULMER, J. D., ROBERTS, W. C., MOSS, M. L., LINE, B. R., & REYNOLDS, H. Y. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-6-769 · Cited by 685
A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro.
Leibovich, S. J., & Ross, R. (1976) · PubMed Central · Cited by 576
The pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Adamson, I. Y. R., & Bowden, D. H. (1974) · PubMed Central · Cited by 549
Surface active materials from dog lung. II. Composition and physiological correlations
King, R., & Clements, J. (1972) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1972.223.3.715 · Cited by 521
Goerke, J. (1974) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(74)90009-4 · Cited by 417
(1956) · The Journal of Pediatrics · doi:10.1016/s0022-3476(56)80109-1 · Cited by 391
Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin.
Thrall, R. S., McCormick, J. R., Jack, R., McReynolds, R. A., & Ward, P. A. (1979) · PubMed Central · Cited by 303
Bone Marrow Graft in Man after Conditioning by Antilymphocytic Serum
Mathé, G., Amiel, J. L., Schwarzenberg, L., Choay, J., Trolard, P., Schneider, M., Hayat, M., Schlumberger, J. R., & Jasmin, C. (1970) · BMJ · doi:10.1136/bmj.2.5702.131 · Cited by 199
Bleomycin: current Status and New Developments
Bush, H. (1979) · British Journal of Cancer · doi:10.1038/bjc.1979.184 · Cited by 196
Morphologic and biochemical study of pulmonary changes induced by bleomycin in mice.
Aso, Y., Yoneda, K., & Kikkawa, Y. (1976) · PubMed · Cited by 190
Research works printed but not linked: 8
- Batenburg JJ, van Golde LMG (1979) Formation of pulmonary surfactant in whole lung and in isolated type II alveolar cells. In: Scarpelli EM, Cosmi EV (eds) Reviews in perinatal medicine, vol 3. Raven Press, New York, pp 73–114
- Cottier H, Hess MW, Keller HU, Schaffner T (1980) Chemokinase, Chemotaxis und Funktion von Phagozyten, mit besonderer Berücksichtigung der Makrophagen. Verh Dtsch Ges Pathol 64:24–62
- Gebbers JO, Burkhardt A, Höltje WJ (1975) Morphologische Lungenveränderungen nach Bleomycin-Therapie. Verh Dtsch Ges Pathol 59:561
- Gebbers JO, Burkhardt A (1978) Die Bleomycin-Lunge als Modell der Schocklunge. Verh Dtsch Ges Pathol 62:390
- Goeckenjan G, Schoppe WD, Bremer G, Schmidt-Gräff A (1980) Verlaufsuntersuchungen der Bleomycin-Lunge unter einer Kortikosteroid-Therapie. Atemwegs Lungenkrankh 6:275–278
- Maeda K, Kosaka H, Yagishita K, Umezawa H (1956) A new antibiotic, phleomycin. J Antibiot (Tokyo) Ser A 9:82–85
- Spector WG (1980) Die Morphologie, Kinetik und Schicksal der Granulome. Verh Dtsch Ges Pathol 64:21–24
- Wicart L (1970) Bleomycin in the treatment of cancer. Progr Antimicrob Anticancer Chemother 2:702–711
Cited by
Extracellular superoxide dismutase in biology and medicine
Fattman, C. L., Schaefer, L. M., & Oury, T. D. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00275-2 · Cited by 651
Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation
Lagares, D., Busnadiego, O., García‐Fernández, R. A., Kapoor, M., Liu, S., Carter, D. E., Abraham, D., Shi‐Wen, X., Carreira, P., Fontaine, B. A., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33482 · Cited by 192
Extracellular Superoxide Dismutase in Pulmonary Fibrosis
Gao, F., Kinnula, V. L., Myllärniemi, M., & Oury, T. D. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1908 · Cited by 131
Ohba, T., McDonald, J. K., Silver, R. M., Strange, C., LeRoy, E. C., & Ludwicka, A. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.10.4.7510986 · Cited by 115
Contractile Cells in Normal and Fibrotic Lung
Adler, K. B., Low, R. B., Leslie, K. O., Mitchell, J., & Evans, J. N. (1990) · Pathology Reviews • 1990 · doi:10.1007/978-1-4612-0485-5_3 · Cited by 107
ROS-induced endothelial stress contributes to pulmonary fibrosis through pericytes and Wnt signaling
Andersson‐Sjöland, A., Karlsson, J., & Rydell‐Törmänen, K. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.100 · Cited by 93
The surfactant system of the adult lung: physiology and clinical perspectives
Hamm, H., Fabel, H., & BARTSCH, W. (1992) · Journal of Molecular Medicine · doi:10.1007/bf00180279 · Cited by 85
Altered expression of extracellular superoxide dismutase in mouse lung after bleomycin treatment
Fattman, C. L., Chu, C. T., Kulich, S. M., Enghild, J. J., & Oury, T. D. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00699-2 · Cited by 75
Oral N-acetylcysteine reduces bleomycin-induced collagen deposition in the lungs of mice
Shahzeidi, S., Särnstrand, B., Jeffery, P. K., McAnulty, R. J., & Laurent, G. J. (1991) · European Respiratory Journal · doi:10.1183/09031936.93.04070845 · Cited by 61
Rydell‐Törmänen, K., Andréasson, K., Hesselstrand, R., Risteli, J., Heinegård, D. K., Saxne, T., & Westergren‐Thorsson, G. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.57 · Cited by 70
Interstitial Pulmonary Fibrosis
Snider, G. L. (1986) · CHEST Journal · doi:10.1378/chest.89.3_supplement.115s · Cited by 38
Riva, E., de Marchi, S. F., Pesenti, A. M., Bizzi, A., Cini, M., Veneroni, E., Tavbani, E., Boeri, R., Bertani, T., & Latini, R. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90635-6 · Cited by 36
Development of a bleomycin hamster model of subchronic lung fibrosis
Zia, S., Hyde, D. M., & Giri, S. N. (1992) · Pathology · doi:10.3109/00313029209063164 · Cited by 34
Brown, R. F. R., Drawbaugh, R. B., & Marrs, T. C. (1988) · Toxicology · doi:10.1016/0300-483x(88)90084-4 · Cited by 32
Comprehensive lung injury pathology induced by mTOR inhibitors
Aparicio, G., Blanco, M., Médina, V., Fernández, O., Jiménez, P., Lema, M., Figueroa, A., & Aparicio, L. M. A. (2009) · Clinical & Translational Oncology · doi:10.1007/s12094-009-0394-y · Cited by 26
Karam, H., Hurbain, I., & HOUSSET, B. (1998) · Cell Biology and Toxicology · doi:10.1023/a:1007460320109 · Cited by 21
Pulmonary responses to bleomycin-induced injury: an immunomorphologic and electron microscopic study
Kumar, R. K., Watkins, S. G., & Lykke, A. W. J. (1985) · Experimental Pathology · doi:10.1016/s0232-1513(85)80030-x · Cited by 20
Pathogenesis of pulmonary fibrosis induced by chrysotile asbestos
Fasske, E. (1986) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00707692 · Cited by 19
Self-citationSteroid Hormone Regulation of Extracellular Matrix Proteins
Cutroneo, K. R., Sterling, K. M., & Shull, S. (1986) · Elsevier eBooks · doi:10.1016/b978-0-12-487425-1.50010-3 · Cited by 18
Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF)
Aribindi, K., Liu, G. Y., & Albertson, T. E. (2024) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2024.2396121 · Cited by 17
Direct toxic effect of bleomycin on alveolar type 2 cells
Karam, H., Hurbain, I., & HOUSSET, B. (1995) · Toxicology Letters · doi:10.1016/0378-4274(94)03207-n · Cited by 15
A new model of diffuse interstitial pulmonary fibrosis in the rat
Selman, M., Montaño, M., MONTFORT, I., & Pérez-Tamayo, R. (1985) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(85)90074-7 · Cited by 15
Yasuda, K., Sato, A., Nishimura, K., Chida, K., & Hayakawa, H. (1994) · Lung · doi:10.1007/bf00185080 · Cited by 14
Lung surfactant as a biophysical assay for inhalation toxicology
Liu, J. Y., & Sayes, C. M. (2022) · Current Research in Toxicology · doi:10.1016/j.crtox.2022.100101 · Cited by 13
Sato, S., Kato, S., Arisaka, Y., TAKAHASHI, H., Takahashi, K., & Tomoike, H. (1993) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.169.233 · Cited by 10
Braun, R., Ferrick, D. A., Sterner‐Kock, A., Kilshaw, P. J., Hyde, D. M., & Giri, S. N. (1996) · Comparative Clinical Pathology · doi:10.1007/bf00368457 · Cited by 9
Schuller, H. M., Smith, A. C., Gregg, M., & Boyd, M. R. (1985) · Experimental Lung Research · doi:10.3109/01902148509057531 · Cited by 6
Fasske, E., & Morgenroth, K. (1985) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02912097 · Cited by 5
Self-citationLuisetti, M., Salmona, M., Pozzi, E., Genghini, M., Spialtini, L., & Masturzo, P. (1987) · Lung · doi:10.1007/bf02714449 · Cited by 4
Interstitial Pulmonary Fibrosis
Schraufnagel, D. E., Claypool, W. C., Fahey, P. J., Jacobs, E. R., Rubin, D. B., & Snider, G. L. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.5.1281 · Cited by 4
Onuma, K., Ebina, M., Takahashi, T., & Nukiwa, T. (2001) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.194.147 · Cited by 3
Lung Toxicity of Chemotherapeutic Agents
Gatzemeier, U. (1995) · Medical radiology · doi:10.1007/978-3-642-46794-3_20 · Cited by 3
Hollinger, M. A., & Giri, S. N. (1990) · Lipids · doi:10.1007/bf02535911 · Cited by 3
Sato, S., Kato, S., TAKAHASHI, H., Takahashi, K., & Yasui, S. (1990) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.161.73 · Cited by 1
Sato, S., Takada, K., Nakamura, H., Yasui, S., & Takahashi, K. (1987) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.152.325 · Cited by 1
Pulmonary toxicity of the combination of bleomycin and peplomycin ? an experimental study in rats
Mall, G., & Burkhardt, A. (1991) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685689 · Cited by 1
Scleroderma as a Fibrotic Disorder
Huffstutter, J. E., & LeRoy, E. C. (1985) · Springer eBooks · doi:10.1007/978-1-4613-2493-5_15
D’Cruz, D. P. (2000) · Elsevier eBooks · doi:10.1016/b978-044450331-2/50042-4
Metadata
- Authors
- Fasske, E., & Morgenroth, K.
- Affiliations
- Research Center Borstel - Leibniz Lung Center (DE)
- Venue
- Lung
- Published
- 1983-12
- Volume
- 161
- Issue
- 1
- Pages
- 133-146
- ISSN
- 0341-2040 (ISSN-L)
- 1432-1750
- OpenAlex
- W2329926543
- Cited by
- 38
- References
- 57
- Citations by year
- 2024: 1 · 2022: 1 · 2015: 1 · 2012: 1
- FWCI
- 4.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Lung (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Keywords
- bleomycin, pulmonary fibrosis, experimental lung injury, interstitial edema, alveolar type II cells, alveolar macrophages, monocyte migration, fibroblast activation, fibril formation
- MeSH terms
- Animals, Bleomycin, Endothelium, Female, Macrophages, Male, Mice, Inbred Strains, Phagocytes, Phagocytosis, Pulmonary Fibrosis, Pulmonary Surfactants, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.